ARHGEF5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.192200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.841200E-01
Normal-vs-Stage2
2.902400E-01
Normal-vs-Stage3
6.059000E-01
Normal-vs-Stage4
4.202600E-01
Stage1-vs-Stage2
5.632200E-01
Stage1-vs-Stage3
8.762800E-01
Stage1-vs-Stage4
8.905200E-01
Stage2-vs-Stage3
7.935800E-01
Stage2-vs-Stage4
7.271000E-01
Stage3-vs-Stage4
9.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.509800E-01
Normal-vs-AfricanAmerican
2.406800E-01
Normal-vs-Asian
2.049800E-01
Caucasian-vs-AfricanAmerican
7.218800E-01
Caucasian-vs-Asian
7.289500E-02
AfricanAmerican-vs-Asian
4.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.405400E-01
Normal-vs-Female
4.577000E-01
Male-vs-Female
5.794300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.862000E-01
Normal-vs-Age(41-60Yrs)
2.735800E-01
Normal-vs-Age(61-80Yrs)
3.930800E-01
Normal-vs-Age(81-100Yrs)
1.652350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.817200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.638000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.696600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.109810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.820200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.578200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.065600E-01
Normal-vs-Daily Drinker
2.000600E-01
Normal-vs-Weekly Drinker
5.019600E-01
Normal-vs-Occasional Drinker
2.299200E-01
Normal-vs-Social Drinker
3.349800E-01
Non Drinker-vs-Daily Drinker
8.576600E-01
Non Drinker-vs-Weekly Drinker
7.013200E-01
Non Drinker-vs-Occasional Drinker
5.550200E-01
Non Drinker-vs-Social Drinker
6.323400E-01
Daily Drinker-vs-Weekly Drinker
5.927200E-01
Daily Drinker-vs-Occasional Drinker
4.337800E-01
Daily Drinker-vs-Social Drinker
4.894400E-01
Weekly Drinker-vs-Occasional Drinker
9.818400E-01
Weekly Drinker-vs-Social Drinker
9.781400E-01
Occasional Drinker-vs-Social Drinker
9.929800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.698200E-02
Normal-vs-Grade 2
1.331960E-02
Normal-vs-Grade 3
1.479530E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.190500E-02
Grade 1-vs-Grade 3
7.935500E-03
Grade 1-vs-Grade 4
3.698200E-02
Grade 2-vs-Grade 3
3.715400E-01
Grade 2-vs-Grade 4
1.331960E-02
Grade 3-vs-Grade 4
1.479530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.496800E-01
Normal-vs-NonDiabetic
2.393800E-01
Diabetic-vs-NonDiabetic
3.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.786500E-02
Normal-vs-NoPancreatitis
3.495200E-01
Pancreatitis-vs-NoPancreatitis
6.06930000000006E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.576000E-01
Normal-vs-N1
3.372800E-01
N0-vs-N1
1.490820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.244100E-02
Normal-vs-TP53-NonMutant
6.065200E-01
TP53-Mutant-vs-TP53-NonMutant
4.550700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
